The functional role of MnSOD as a biomarker of human diseases and therapeutic potential of a new isoform of a human recombinant MnSOD

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Borrelli, Antonella ^a   Schiattarella, Antonietta ^a   Bonelli, Patrizia ^a   Tuccillo, Franca Maria ^a   Buonaguro, Franco Maria ^a   Mancini, Aldo ^a  

^a IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CATALASE; COPPER PROTEIN; COPPER ZINC SUPEROXIDE DISMUTASE; ESTROGEN RECEPTOR; GLUTATHIONE PEROXIDASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERSTITIAL COLLAGENASE; MANGANESE SUPEROXIDE DISMUTASE; PROTEIN 14 3 3; PROTEIN P53; REACTIVE OXYGEN METABOLITE; RECOMBINANT ENZYME; RECOMBINANT MANGANESE SUPEROXIDE DISMUTASE; SECRETORY PROTEIN; SIGNAL PEPTIDE; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; ANTIOXIDANT; BIOLOGICAL MARKER; ISOPROTEIN; SUPEROXIDE DISMUTASE;

ACUTE GRAFT REJECTION; BREAST CARCINOMA; CANCER CELL; CANCER CHEMOTHERAPY; CANCER THERAPY; CHLOROPLAST; CHROMOSOMAL INSTABILITY; CYTOTOXICITY; DISEASE MARKER; DNA DAMAGE; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; LIPOSARCOMA; MOLECULAR WEIGHT; NONHUMAN; OVARY ADENOCARCINOMA; OXIDATIVE STRESS; PHASE 1 CLINICAL TRIAL (TOPIC); PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; RADIATION PROTECTION; RADIODIAGNOSIS; REVIEW; GENETICS; METABOLISM; MITOCHONDRION; MOLECULARLY TARGETED THERAPY; PATHOLOGY; TUMOR CELL LINE;

ANTIOXIDANTS; BIOLOGICAL MARKERS; CELL LINE, TUMOR; HUMANS; LIPOSARCOMA; MITOCHONDRIA; MOLECULAR TARGETED THERAPY; PROTEIN ISOFORMS; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE;

EID: 84893374757     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/476789     Document Type: Review

References (147)

1. Kathiria A. S., Butcher L. D., Feagins L. A., Souza R. F., Boland C. R., Theiss A. L., Prohibitin 1 modulates mitochondrial stress-related autophagy in human colonic epithelial cells. PLoS One 2012 7 2 e31231 2-s2.0-84857186085 10.1371/journal.pone.0031231
2. Hamanaka R. B., Chandel N. S., Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes. Trends in Biochemical Sciences 2010 35 9 505 513 2-s2.0-77956186783 10.1016/j.tibs.2010. 04.002
3. Matés J. M., Pérez-Gómez C., Núñez de Castro I., Antioxidant enzymes and human diseases. Clinical Biochemistry 1999 32 8 595 603 10.1016/S0009-9120(99)00075-2 (Pubitemid 30039087)
4. Matés J. M., Segura J. A., Alonso F. J., Márquez J., Roles of dioxins and heavy metals in cancer and neurological diseases using ROS-mediated mechanisms. Free Radical Biology and Medicine 2010 49 9 1328 1341 2-s2.0-77957128195 10.1016/j.freeradbiomed.2010.07.028
5. Matés J. M., Segura J. A., Alonso F. J., Márquez J., Intracellular redox status and oxidative stress: implications for cell proliferation, apoptosis, and carcinogenesis. Archives of Toxicology 2008 82 5 273 299 2-s2.0-43749092334 10.1007/s00204-008-0304-z
6. Raj L., Ide T., Gurkar A. U., Foley M., Schenone M., Li X., Tolliday N. J., Golub T. R., Carr S. A., Shamji A. F., Stern A. M., Mandinova A., Schreiber S. L., Lee S. W., Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Nature 2011 475 7355 231 234 2-s2.0-79960427057 10.1038/nature10167
7. Sosa V., Moliné T., Somoza R., Paciucci R., Kondoh H., LLeonart M. E., Oxidative stress and cancer: an overview. Ageing Research Reviews 2013 12 1 376 390 10.1016/j.arr.2012.10.004
8. Boillée S., Velde V. C., Cleveland D. W., ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 2006 52 1 39 59 2-s2.0-33749056809 10.1016/j.neuron.2006.09.018 (Pubitemid 44466358)
9. Brazier M. W., Doctrow S. R., Masters C. L., Collins S. J., A manganese-superoxide dismutase/catalase mimetic extends survival in a mouse model of human prion disease. Free Radical Biology and Medicine 2008 45 2 184 192 2-s2.0-44649107650 10.1016/j.freeradbiomed.2008.04.006
10. Christen Y., Oxidative stress and Alzheimer disease. The American Journal of Clinical Nutrition 2000 71 2 621S 629S (Pubitemid 30061247)
11. Fukui H., Moraes C. T., The mitochondrial impairment, oxidative stress and neurodegeneration connection: reality or just an attractive hypothesis? Trends in Neurosciences 2008 31 5 251 256 2-s2.0-42749087763 10.1016/j.tins.2008.02.008
12. Miller R. L., James-Kracke M., Sun G. Y., Sun A. Y., Oxidative and inflammatory pathways in Parkinson's disease. Neurochemical Research 2009 34 1 55 65 2-s2.0-58149466868 10.1007/s11064-008-9656-2
13. Wang J.-F., Defects of mitochondrial electron transport chain in bipolar disorder: implications for mood-stabilizing treatment. The Canadian Journal of Psychiatry 2007 52 12 753 762 2-s2.0-37749029999
14. Crimi E., Ignarro L. J., Napoli C., Microcirculation and oxidative stress. Free Radical Research 2007 41 12 1364 1375 2-s2.0-37349048328 10.1080/10715760701732830 (Pubitemid 350302192)
15. Hoshino T., Okamoto M., Takei S., Sakazaki Y., Iwanaga T., Aizawa H., Redox-regulated mechanisms in asthma. Antioxidants & Redox Signaling 2008 10 4 769 783 2-s2.0-38949207260 10.1089/ars.2007.1936 (Pubitemid 351225896)
16. Figueroa-Romero C., Sadidi M., Feldman E. L., Mechanisms of disease: the oxidative stress theory of diabetic neuropathy. Reviews in Endocrine and Metabolic Disorders 2008 9 4 301 314 2-s2.0-54949157826 10.1007/s11154-008-9104- 2
17. Hoshino Y., Mishima M., Redox-based therapeutics for lung diseases. Antioxidants & Redox Signaling 2008 10 4 701 704 2-s2.0-38949085943 10.1089/ars.2007.1961 (Pubitemid 351225907)
18. Aslan M., Cort A., Yucel I., Oxidative and nitrative stress markers in glaucoma. Free Radical Biology and Medicine 2008 45 4 367 376 2-s2.0-46649083004 10.1016/j.freeradbiomed.2008.04.026
19. Nilsson J., Bengtsson E., Fredrikson G. N., Björkbacka H., Inflammation and immunity in diabetic vascular complications. Current Opinion in Lipidology 2008 19 5 519 524 2-s2.0-53549101280 10.1097/MOL.0b013e32830f47cd
20. Shoham A., Hadziahmetovic M., Dunaief J. L., Mydlarski M. B., Schipper H. M., Oxidative stress in diseases of the human cornea. Free Radical Biology and Medicine 2008 45 8 1047 1055 2-s2.0-53049091680 10.1016/j.freeradbiomed.2008.07. 021
21. Ungvari Z., Parrado-Fernandez C., Csiszar A., de Cabo R., Mechanisms underlying caloric restriction and lifespan regulation: implications for vascular aging. Circulation Research 2008 102 5 519 529 2-s2.0-40949142846 10.1161/CIRCRESAHA.107.168369 (Pubitemid 351416750)
22. Boveris A., Navarro A., Brain mitochondrial dysfunction in aging. IUBMB Life 2008 60 5 308 314 2-s2.0-46349093995 10.1002/iub.46
23. Brown N. S., Bicknell R., Hypoxia and oxidative stress in breast cancer: oxidative stress-its effects on the growth, metastatic potential and response to therapy of breast cancer. Breast Cancer Research 2001 3 5 323 327 2-s2.0-0034855105 10.1186/bcr315 (Pubitemid 32851163)
24. Csiszar A., Wang M., Lakatta E. G., Ungvari Z., Inflammation and endothelial dysfunction during aging: role of NF- B. Journal of Applied Physiology 2008 105 4 1333 1341 2-s2.0-55449136486 10.1152/japplphysiol.90470. 2008
25. Toyokuni S., Molecular mechanisms of oxidative stress-induced carcinogenesis: from epidemiology to oxygenomics. IUBMB Life 2008 60 7 441 447 2-s2.0-48849114365 10.1002/iub.61
26. Mocellin S., Bronte V., Nitti D., Nitric oxide, a double edged sword in cancer biology: searching for therapeutic opportunities. Medicinal Research Reviews 2007 27 3 317 352 2-s2.0-34247613216 10.1002/med.20092 (Pubitemid 46668937)
27. Bartesaghi S., Ferrer-Sueta G., Peluffo G., Valez V., Zhang H., Kalyanaraman B., Radi R., Protein tyrosine nitration in hydrophilic and hydrophobic environments. Amino Acids 2007 32 4 501 515 2-s2.0-34249101633 10.1007/s00726-006-0425-8 (Pubitemid 46790931)
28. Bonello S., Zähringer C., BelAiba R. S., Djordjevic T., Hess J., Michiels C., Kietzmann T., Görlach A., Reactive oxygen species activate the HIF-1 promoter via a functional NF B site. Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 4 755 761 2-s2.0-34247187576 10.1161/01.ATV.0000258979. 92828.bc (Pubitemid 46606703)
29. Du W., Adam Z., Rani R., Zhang X., Pang Q., Oxidative stress in Fanconi anemia hematopoiesis and disease progression. Antioxidants & Redox Signaling 2008 10 11 1909 1921 2-s2.0-51349138695 10.1089/ars.2008.2129
30. Hidalgo C., Donoso P., Crosstalk between calcium and redox signaling: from molecular mechanisms to health implications. Antioxidants & Redox Signaling 2008 10 7 1275 1312 2-s2.0-43049153016 10.1089/ars.2007.1886 (Pubitemid 351634396)
31. Li F., Sonveaux P., Rabbani Z. N., Liu S., Yan B., Huang Q., Vujaskovic Z., Dewhirst M., Li C.-Y., Regulation of HIF-1 stability through S-nitrosylation. Molecular Cell 2007 26 1 63 74 2-s2.0-34047272690 10.1016/j.molcel.2007.02.024 (Pubitemid 46550936)
32. Rubbo H., Radi R., Protein and lipid nitration: role in redox signaling and injury. Biochimica et Biophysica Acta 2008 1780 11 1318 1324 2-s2.0-49349115115 10.1016/j.bbagen.2008.03.007
33. Salvemini D., Doyle T. M., Cuzzocrea S., Superoxide, peroxynitrite and oxidative/nitrative stress in inflammation. Biochemical Society Transactions 2006 34 5 965 970 2-s2.0-33751288381 10.1042/BST0340965 (Pubitemid 44796461)
34. Souza J. M., Peluffo G., Radi R., Protein tyrosine nitration-functional alteration or just a biomarker? Free Radical Biology and Medicine 2008 45 4 357 366 2-s2.0-46649090918 10.1016/j.freeradbiomed.2008.04.010
35. Winterbourn C. C., Reconciling the chemistry and biology of reactive oxygen species. Nature Chemical Biology 2008 4 5 278 286 2-s2.0-42249088093 10.1038/nchembio.85 (Pubitemid 351550893)
36. Winterbourn C. C., Hampton M. B., Thiol chemistry and specificity in redox signaling. Free Radical Biology and Medicine 2008 45 5 549 561 2-s2.0-48449107159 10.1016/j.freeradbiomed.2008.05.004
37. McCord J. M., Edeas M. A., SOD, oxidative stress and human pathologies: a brief history and a future vision. Biomedicine & Pharmacotherapy 2005 59 4 139 142 2-s2.0-18044363639 10.1016/j.biopha.2005.03.005 (Pubitemid 40603324)
38. Pauling L., The discovery of the superoxide radical. Trends in Biochemical Sciences 1979 4 11 N270 N271 2-s2.0-0001280808
39. Mann T., Keilin D., Haemocuprein and hepatocuprein, copper protein compounds of blood and liver in mammals. Proceedings of the Royal Society B 1938 126 844 303 315 10.1098/rspb.1938.0058
40. Huber W., Schulte T. L., Carson S., Goldhamer R. E., Vogin E. E., Some chemical and pharmacologic properties of a novel anti-inflammatory protein. Toxicology and Applied Pharmacology 1968 12 308
41. Knowles P. F., Gibson J. F., Pick F. M., Bray R. C., Electron-spin- resonance evidence for enzymic reduction of oxygen to a free radical, the superoxide ion. Biochemical Journal 1969 111 1 53 58 2-s2.0-0014446671
42. McCord J. M., Fridovich I., Superoxide dismutase. an enzymic function for erythrocuprein (hemocuprein). The Journal of Biological Chemistry 1969 244 22 6049 6055 2-s2.0-0014691242
43. McCord J. M., Fridovich I., The reduction of cytochrome c by milk xanthine oxidase. The Journal of Biological Chemistry 1968 243 21 5753 5760 2-s2.0-0014410114
44. Pica A., Di Santi A., Basile F., Iacobellis F., Borrelli A., Schiattarella A., Mancini R., Mancini A., Anti-Cancer, anti-Necrotic and Imaging Tumor Marker role of a novel form of Manganese Superoxide Dismutase and its leader peptide. International Journal of Biology and Biomedical Engineering 2010 4 3 53 60
45. Banci L., Bertini I., Cramaro F., Del Conte R., Viezzoli M. S., The solution structure of reduced dimeric copper zinc superoxide dismutase: the structural effects of dimerization. European Journal of Biochemistry 2002 269 7 1905 1915 2-s2.0-0036231449 10.1046/j.1432-1327.2002.02840.x (Pubitemid 34429672)
46. Liochev S. I., Fridovich I., Mechanism of the peroxidase activity of Cu, Zn superoxide dismutase. Free Radical Biology and Medicine 2010 48 12 1565 1569 2-s2.0-77952674667 10.1016/j.freeradbiomed.2010.02.036
47. Cho G., Kang S., Seo S. J., Kim Y., Jung G., The transcriptional repression of the human Cu/Zn superoxide dismutase(sod1) gene by the anticancer drug, mitomycin C(MMC). Biochemistry and Molecular Biology International 1997 42 5 949 956 2-s2.0-0031398623 (Pubitemid 28297586)
48. Fukai T., Ushio-Fukai M., Superoxide dismutases: role in redox signaling, vascular function, and diseases. Antioxidants & Redox Signaling 2011 15 6 1583 1606 2-s2.0-79961193678 10.1089/ars.2011.3999
49. Matés J. M., Sánchez-Jiménez F., Role of reactive oxygen species in apoptosis: implications for cancer therapy. The International Journal of Biochemistry & Cell Biology 2000 32 2 157 170 (Pubitemid 30001819)
50. Sentman M.-L., Brännström T., Marklund S. L., EC-SOD and the response to inflammatory reactions and aging in mouse lung. Free Radical Biology and Medicine 2002 32 10 975 981 2-s2.0-0037093715 10.1016/S0891-5849(02)00790-6 (Pubitemid 34465649)
51. Bowler R. P., Nicks M., Olsen D. A., Thøgersen I. B., Valnickova Z., Højrup P., Franzusoff A., Enghild J. J., Crapo J. D., Furin proteolytically processes the heparin-binding region of extracellular superoxide dismutase. The Journal of Biological Chemistry 2002 277 19 16505 16511 2-s2.0-0037053387 10.1074/jbc.M105409200 (Pubitemid 34967665)
52. + progenitor cells corresponds to increased drug sensitivity and apoptotic response. Blood 2002 100 3 845 853 2-s2.0-0036683450 10.1182/blood-2002-01-0022 (Pubitemid 34832609)
53. Nozik-Grayck E., Suliman H. B., Piantadosi C. A., Extracellular superoxide dismutase. The International Journal of Biochemistry & Cell Biology 2005 37 12 2466 2471 2-s2.0-25844451964 10.1016/j.biocel.2005.06.012 (Pubitemid 41400317)
54. Levin E. D., Christopher N. C., Lateef S., Elamir B. M., Patel M., Liang L.-P., Crapo J. D., Extracellular superoxide dismutase overexpression protects against aging-induced cognitive impairment in mice. Behavior Genetics 2002 32 2 119 125 2-s2.0-0036096823 10.1023/A:1015201823417 (Pubitemid 34522420)
55. Carlioz A., Touati D., Isolation of superoxide dismutase mutants in Escherichia coli: is superoxide dismutase necessary for aerobic life? The EMBO Journal 1986 5 3 623 630 2-s2.0-0022683672
56. Farr S. B., D'Ari R., Touati D., Oxygen-dependent mutagenesis in Escherichia coli lacking superoxide dismutase. Proceedings of the National Academy of Sciences of the United States of America 1986 83 21 8268 8272 2-s2.0-0001298780 (Pubitemid 17182482)
57. Shimizu T., Nojiri H., Kawakami S., Uchiyama S., Shirasawa T., Model mice for tissue-specific deletion of the manganese superoxide dismutase gene. Geriatrics & Gerontology International 2010 10 1 S70 S79 2-s2.0-77954684897 10.1111/j.1447-0594.2010.00604.x
58. Dhar S. K., St. Clair D. K., Manganese superoxide dismutase regulation and cancer. Free Radical Biology and Medicine 2012 52 11-12 2209 2222 10.1016/j.freeradbiomed.2012.03.009
59. Meyrick B., Magnuson M. A., Identification and functional characterization of the bovine manganous superoxide dismutase promoter. American Journal of Respiratory Cell and Molecular Biology 1994 10 1 113 121 2-s2.0-0028098668
60. Church S. L., Grant J. W., Meese E. U., Trent J. M., Sublocalization of the gene encoding manganese superoxide dismutase (MnSOD/SOD2) to 6q25 by fluorescence in Situ hybridization and somatic cell hybrid mapping. Genomics 1992 14 3 823 825 2-s2.0-0026499456 10.1016/S0888-7543(05)80202-2
61. Bravard A., Sabatier L., Hoffschir F., Ricoul M., Luccioni C., Dutrillaux B., SOD2: a new type of tumor-suppressor gene? The International Journal of Cancer 1992 51 3 476 480 2-s2.0-0026650916 10.1002/ijc.2910510323
62. Borrello S., De Leo M. E., Galeotti T., Defective gene expression of MnSOD in cancer cells. Molecular Aspects of Medicine 1993 14 3 253 258 2-s2.0-0027380170 10.1016/0098-2997(93)90012-3
63. St. Clair D. K., Holland J. C., Complementary DNA encoding human colon cancer manganese superoxide dismutase and the expression of its gene in human cells. Cancer Research 1991 51 3 939 943 2-s2.0-0026033905
64. Izutani R., Asano S., Imano M., Kuroda D., Kato M., Ohyanagi H., Expression of manganese superoxide dismutase in esophageal and gastric cancers. Journal of Gastroenterology 1998 33 6 816 822 2-s2.0-0032458363 10.1007/s005350050181 (Pubitemid 29271542)
65. Ho J. C.-M., Zheng S., Comhair S. A. A., Farver C., Erzurum S. C., Differential expression of manganese superoxide dismutase and catalase in lung cancer. Cancer Research 2001 61 23 8578 8585 2-s2.0-0035577304 (Pubitemid 33131142)
66. Toh Y., Kuninaka S., Oshiro T., Ikeda Y., Nakashima H., Baba H., Kohnoe S., Okamura T., Mori M., Sugimachi K., Overexpression of manganese superoxide dismutase mRNA may correlate with aggressiveness in gastric and colorectal adenocarcinomas. International Journal of Oncology 2000 17 1 107 112 2-s2.0-17444434912
67. Malafa M., Margenthaler J., Webb B., Neitzel L., Christophersen M., MnSOD expression is increased in metastatic gastric cancer. Journal of Surgical Research 2000 88 2 130 134 2-s2.0-0033963752 10.1006/jsre.1999.5773 (Pubitemid 30085842)
68. Janssen A. M. L., Bosman C. B., van Duijn W., Oostendorp-van de Ruit M. M., Kubben F. J. G. M., Griffioen G., Lamers C. B. H. W., van Krieken J. H. J. M., van de Velde C. J. H., Verspaget H. W., Superoxide dismutases in gastric and esophageal cancer and the prognostic impact in gastric cancer. Clinical Cancer Research 2000 6 8 3183 3192 2-s2.0-0033900975 (Pubitemid 30637746)
69. Weydert C., Roling B., Liu J., Hinkhouse M. M., Ritchie J. M., Oberley L. W., Cullen J. J., Suppression of the malignant phenotype in human pancreatic cancer cells by the overexpression of manganese superoxide dismutase. Molecular Cancer Therapeutics 2003 2 4 361 369 2-s2.0-0346363268
70. Oberley L. W., Buettner G. R., Role of superoxide dismutase in cancer: a review. Cancer Research 1979 39 4 1141 1149 2-s2.0-0018749490 (Pubitemid 9183825)
71. Soini Y., Vakkala M., Kahlos K., Pääkkö P., Kinnula V., MnSOD expression is less frequent in tumour cells of invasive breast carcinomas than in in situ carcinomas or non-neoplastic breast epithelial cells. The Journal of Pathology 2001 195 2 156 162 2-s2.0-0034802050 10.1002/path.946 (Pubitemid 32899023)
72. Chuang T.-C., Liu J.-Y., Lin C.-T., Tang Y.-T., Yeh M.-H., Chang S.-C., Li J.-W., Kao M.-C., Human manganese superoxide dismutase suppresses HER2/neu-mediated breast cancer malignancy. FEBS Letters 2007 581 23 4443 4449 2-s2.0-34548417990 10.1016/j.febslet.2007.08.021 (Pubitemid 47368202)
73. Cullen J. J., Weydert C., Hinkhouse M. M., Ritchie J., Domann F. E., Spitz D., Oberley L. W., The role of manganese superoxide dismutase in the growth of pancreatic adenocarcinoma. Cancer Research 2003 63 6 1297 1303 2-s2.0-0037444154 (Pubitemid 36348708)
74. Hu Y., Rosen D. G., Zhou Y., Feng L., Yang G., Liu J., Huang P., Mitochondrial manganese-superoxide dismutase expression in ovarian cancer: role in cell proliferation and response to oxidative stress. The Journal of Biological Chemistry 2005 280 47 39485 39492 2-s2.0-28244447656 10.1074/jbc.M503296200 (Pubitemid 41713906)
75. Liu R., Oberley T. D., Oberley L. W., Transfection and expression of MnSOD cDNA decreases tumor malignancy of human oral squamous carcinoma SCC-25 cells. Human Gene Therapy 1997 8 5 585 595 2-s2.0-0030958392 (Pubitemid 27202050)
76. Venkataraman S., Jiang X., Weydert C., Zhang Y., Zhang H. J., Goswami P. C., Ritchie J. M., Oberley L. W., Buettner G. R., Manganese superoxide dismutase overexpression inhibits the growth of androgen-independent prostate cancer cells. Oncogene 2005 24 1 77 89 2-s2.0-12444278251 10.1038/sj.onc.1208145 (Pubitemid 40143867)
77. Cullen J. J., Mitros F. A., Oberley L. W., Expression of antioxidant enzymes in diseases of the human pancreas: another link between chronic pancreatitis and pancreatic cancer. Pancreas 2003 26 1 23 27 (Pubitemid 36020262)
78. Behrend L., Mohr A., Dick T., Zwacka R. M., Manganese superoxide dismutase induces p53-dependent senescence in colorectal cancer cells. Molecular and Cellular Biology 2005 25 17 7758 7769 2-s2.0-23844456959 10.1128/MCB.25.17.7758-7769.2005 (Pubitemid 41170136)
79. Oberley L. W., Mechanism of the tumor suppressive effect of MnSOD overexpression. Biomedicine & Pharmacotherapy 2005 59 4 143 148 2-s2.0-18044364791 10.1016/j.biopha.2005.03.006 (Pubitemid 40603325)
80. Zhao Y., Xue Y., Oberley T. D., Kiningham K. K., Lin S.-M., Yen H.-C., Majima H., Hines J., St. Clair D., Overexpression of manganese superoxide dismutase suppresses tumor formation by modulation of activator protein-1 signaling in a multistage skin carcinogenesis model. Cancer Research 2001 61 16 6082 6088 2-s2.0-0035881315 (Pubitemid 32762543)
81. Zhao Y., Oberley T. D., Chaiswing L., Lin S.-M., Epstein C. J., Huang T.-T., St. Clair D., Manganese superoxide dismutase deficiency enhances cell turnover via tumor promoter-induced alterations in AP-1 and p53-mediated pathways in a skin cancer model. Oncogene 2002 21 24 3836 3846 2-s2.0-0037198635 10.1038/sj/onc/1205477 (Pubitemid 34620851)
82. van de Wetering C. I., Coleman M. C., Spitz D. R., Smith B. J., Knudson C. M., Manganese superoxide dismutase gene dosage affects chromosomal instability and tumor onset in a mouse model of T cell lymphoma. Free Radical Biology and Medicine 2008 44 8 1677 1686 2-s2.0-41149117395 10.1016/j. freeradbiomed.2008.01.022
83. Holley A. K., Bakthavatchalu V., Velez-Roman J. M., St. Clair D. K., Manganese superoxide dismutase: guardian of the powerhouse. International Journal of Molecular Sciences 2011 12 10 7114 7162 2-s2.0-80055035014 10.3390/ijms12107114
84. Holley A. K., Dhar S. K., Xu Y., St Clair D. K., Manganese superoxide dismutase: beyond life and death. Amino acids 2012 42 1 139 158 2-s2.0-84858157091 10.1007/s00726-010-0600-9
85. Ridnour L. A., Oberley T. D., Oberley L. W., Tumor suppressive effects of MnSOD overexpression may involve imbalance in perokide generation versus peroxide removal. Antioxidants & Redox Signaling 2004 6 3 501 512 2-s2.0-2442595951 (Pubitemid 38625371)
86. Kim A., Modulation of MnSOD in cancer: epidemiological and experimental evidence. Toxicological Research 2010 26 2 83 93 10.5487/TR.2010.26.2.083
87. Zhang Y., Smith B. J., Oberley L. W., Enzymatic activity is necessary for the tumor-suppressive effects of MnSOD. Antioxidants & Redox Signaling 2006 8 7-8 1283 1293 2-s2.0-33746851285 10.1089/ars.2006.8.1283 (Pubitemid 44182427)
88. Li N., Oberley T. D., Oberley L. W., Zhong W., Overexpression of manganese superoxide dismutase in DU145 human prostate carcinoma cells has mutliple effects on cell phenotype. Prostate 1998 35 3 221 233 (Pubitemid 28211296)
89. Davis C. A., Hearn A. S., Fletcher B., Bickford J., Garcia J. E., Leveque V., Melendez J. A., Silverman D. N., Zucali J., Agarwal A., Nick H. S., Potent anti-tumor effects of an active site mutant of human manganese-superoxide dismutase: evolutionary conservation of product inhibition. The Journal of Biological Chemistry 2004 279 13 12769 12776 2-s2.0-11144354714 10.1074/jbc.M310623200 (Pubitemid 38445849)
90. Jang Y. C., Pérez V. I., Song W., Lustgarten M. S., Salmon A. B., Mele J., Qi W., Liu Y., Liang H., Chaudhuri A., Ikeno Y., Epstein C. J., van Remmen H., Richardson A., Overexpression of Mn superoxide dismutase does not increase life span in mice. The Journals of Gerontology A 2009 64 11 1114 1125 2-s2.0-70350439125 10.1093/gerona/glp100
91. Maritim A. C., Sanders R. A., Watkins J. B. III, Diabetes, oxidative stress, and antioxidants: a review. Journal of Biochemical and Molecular Toxicology 2003 17 1 24 38 2-s2.0-0037253073 10.1002/jbt.10058 (Pubitemid 36410972)
92. Gao B., Flores S. C., Leff J. A., Bose S. K., McCord J. M., Synthesis and anti-inflammatory activity of a chimeric recombinant superoxide dismutase: SOD2/3. American Journal of Physiology: Lung Cellular and Molecular Physiology 2003 284 6 L917 L925 2-s2.0-0037497967 (Pubitemid 36687126)
93. Inoue M., Ebashi I., Watanabe N., Morino Y., Synthesis of a superoxide dismutase derivative that circulates bound to albumin and accumulates in tissues whose pH is decreased. Biochemistry 1989 28 16 6619 6624 2-s2.0-0024353121 (Pubitemid 19208311)
94. Freeman B. A., Young S. L., Crapo J. D., Liposome-mediated augmentation of superoxide dismutase in endothelial cells prevents oxygen injury. The Journal of Biological Chemistry 1983 258 20 12534 12542 2-s2.0-0021089950 (Pubitemid 14231172)
95. Turrens J. F., Crapo J. D., Freeman B. A., Protection against oxygen toxicity by intravenous injection of liposome-entrapped catalase and superoxide dismutase. The Journal of Clinical Investigation 1984 73 1 87 95 2-s2.0-0021352122 (Pubitemid 14222651)
96. Marberger H., Huber W., Bartsch G., Orgotein: a new antiinflammatory metalloprotein drug. evaluation of clinical efficacy and safety in inflammatory conditions of the urinary tract. International Urology and Nephrology 1974 6 2 61 74 2-s2.0-0016208752
97. Delanian S., Martin M., Bravard A., Luccioni C., Lefaix J.-L., Cu/Zn superoxide dismutase modulates phenotypic changes in cultured fibroblasts from human skin with chronic radiotherapy damage. Radiotherapy & Oncology 2001 58 3 325 331 2-s2.0-0035282768 10.1016/S0167-8140(00)00332-7 (Pubitemid 32181868)
98. Emerit J., Michelson A. M., Robert H. G., Chomette G., Guerin R. A., Blondon J., [Superoxide dismutase treatment of 2 cases of radiation-induced sclerosis]. La Semaine des Hôpitaux 1983 59 4 277 281 (Pubitemid 13114287)
99. Land W., Schneeberger H., Schleibner S., Illner W.-D., Abendroth D., Rutili G., Arfors K. E., Messmer K., The beneficial effect of human recombinant superoxide dismutase on acute and chronic rejection events in recipients of cadaveric renal transplants. Transplantation 1994 57 2 211 217 2-s2.0-0027979555 (Pubitemid 24048587)
100. Matzinger P., The danger model: a renewed sense of self. Science 2002 296 5566 301 305 2-s2.0-0037066427 10.1126/science.1071059 (Pubitemid 34303674)
101. Buetler T. M., Krauskopf A., Ruegg U. T., Role of superoxide as a signaling molecule. News in Physiological Sciences 2004 19 3 120 123 2-s2.0-3042807919 10.1152/nips.01514.2003
102. Werner E., GTPases and reactive oxygen species: switches for killing and signaling. Journal of Cell Science 2004 117 2 143 153 2-s2.0-1642462459 10.1242/jcs.00937 (Pubitemid 38128895)
103. Ough M., Lewis A., Zhang Y., Hinkhouse M. M., Ritchie J. M., Oberley L. W., Cullen J. J., Inhibition of cell growth by overexpression of manganese superoxide dismutase (MnSOD) in human pancreatic carcinoma. Free Radical Research 2004 38 11 1223 1233 10.1080/10715760400017376 (Pubitemid 39654512)
104. Arbiser J. L., Petros J., Klafter R., Govindajaran B., McLaughlin E. R., Brown L. F., Cohen C., Moses M., Kilroy S., Arnold R. S., Lambeth J. D., Reactive oxygen generated by Nox1 triggers the angiogenic switch. Proceedings of the National Academy of Sciences of the United States of America 2002 99 2 715 720 2-s2.0-0037154250 10.1073/pnas.022630199 (Pubitemid 34106576)
105. Sorescu D., Weiss D., Lassègue B., Clempus R. E., Szöcs K., Sorescu G. P., Valppu L., Quinn M. T., Lambeth J. D., Vega J. D., Taylor W. R., Griendling K. K., Superoxide production and expression of Nox family proteins in human atherosclerosis. Circulation 2002 105 12 1429 1435 2-s2.0-0037177164 10.1161/01.CIR.0000012917.74432.66 (Pubitemid 34263273)
106. Chaiswing L., Zhong W., Cullen J. J., Oberley L. W., Oberley T. D., Extracellular redox state regulates features associated with prostate cancer cell invasion. Cancer Research 2008 68 14 5820 5826 2-s2.0-48649095595 10.1158/0008-5472.CAN-08-0162
107. Duffy A. M., O'Brien T., McMahon J. M., Generation of antioxidant adenovirus gene transfer vectors encoding CuZnSOD, MnSOD, and catalase. Methods in Molecular Biology 2010 594 381 393 2-s2.0-77950348673 10.1007/978-1-60761- 411-1-27
108. Yang J.-Q., Buettner G. R., Domann F. E., Li Q., Engelhardt J. F., Weydert C. D., Oberley L. W., v-Ha- ras mitogenic signaling through superoxide and derived reactive oxygen species. Molecular Carcinogenesis 2002 33 4 206 218 2-s2.0-0036219617 10.1002/mc.10037 (Pubitemid 34297128)
109. Yang J. Q., Li S., Domann F. E., Superoxide generation in v-Ha- ras -transduced human keratinocyte HaCaT cells. Molecular Carcinogenesis 1999 26 3 180 188 (Pubitemid 29529569)
110. Tarhini A. A., Belani C. P., Luketich J. D., Argiris A., Ramalingam S. S., Gooding W., Pennathur A., Petro D., Kane K., Liggitt D., Championsmith T., Zhang X., Epperly M. W., Greenberger J. S., A phase I study of concurrent chemotherapy (paclitaxel and carboplatin) and thoracic radiotherapy with swallowed manganese superoxide dismutase plasmid liposome protection in patients with locally advanced stage III non-small-cell lung cancer. Human Gene Therapy 2011 22 3 336 342 2-s2.0-79952686010 10.1089/hum.2010.078
111. Epperly M. W., Carpenter M., Agarwal A., Mitra P., Nie S., Greenberger J. S., Intraoral manganese superoxide dismutase-plasmid/liposome (MnSOD-PL) radioprotective gene therapy decreases ionizing irradiation-induced murine mucosal cell cycling and apoptosis. In Vivo 2004 18 4 401 410 2-s2.0-4444382738 (Pubitemid 39199983)
112. Epperly M. W., Epstein C. J., Travis E. L., Greenberger J. S., Decreased pulmonary radiation resistance of manganese superoxide dismutase (MnSOD)-deficient mice is corrected by human manganese superoxide dismutase-plasmid/liposome (SOD2-PL) intratracheal gene therapy. Radiation Research 2000 154 4 365 374 2-s2.0-0033809159
113. Mancini A., Borrelli A., Schiattarella A., Fasano S., Occhiello A., Pica A., Sehr P., Tommasino M., Nüesch J. P. F., Rommelaere J., Tumor suppressive activity of a variant isoform of manganese superoxide dismutase released by a human liposarcoma cell line. The International Journal of Cancer 2006 119 4 932 943 2-s2.0-33745899608 10.1002/ijc.21904 (Pubitemid 44051461)
114. Mancini A., Garbi C., D'Armiento F., Borrelli A., Ambesi-Impiombato F. S., Culture and cloning of an adipocytes cell line from a human liposarcoma. Bollettino dell'Istituto dei Tumori di Napoli 1991 38 43 49
115. Mancini A., Borrelli A., Formisano S., Masucci M. T., Maffeo A., Perla G., De Martino L., Bevilacqua N., Botti G., Maggino T., Establishment and growth regulation of a novel ovarian cancer cell line from a poorly-differentiated adenocarcinoma: proposal for a new treatment. European Journal of Gynaecological Oncology 1999 20 1 45 52 2-s2.0-0033017722 (Pubitemid 29108251)
116. Mancini A., Borrelli A., Masucci M. T., Schiattarella A., Filice S., Rashan J., Maggino T., A conditioned medium from a human liposarcoma-derived cell line induces p53-dependent apoptosis in several tumor cell lines. Oncology Reports 2000 7 3 629 637 2-s2.0-0034185678
117. Mancini A., Borrelli A., Schiattarella A., Aloj L., Aurilio M., Morelli F., Pica A., Occhiello A., Lorizio R., Mancini R., Sica A., Mazzarella L., Sica F., Grieco P., Novellino E., Pagnozzi D., Pucci P., Rommelaere J., Biophysical and biochemical characterization of a liposarcoma-derived recombinant MnSOD protein acting as an anticancer agent. The International Journal of Cancer 2008 123 11 2684 2695 2-s2.0-57349198688 10.1002/ijc.23791
118. Borrelli A., Schiattarella A., Mancini R., Morrica B., Cerciello V., Mormile M., d'Alesio V., Bottalico L., Morelli F., D'Armiento M., D'Armiento F. P., Mancini A., A recombinant MnSOD is radioprotective for normal cells and radiosensitizing for tumor cells. Free Radical Biology and Medicine 2009 46 1 110 116 2-s2.0-57649093466 10.1016/j.freeradbiomed.2008.10.030
119. Borrelli A., Schiattarella A., Mancini R., Morelli F., Capasso C., De Luca V., Gori E., Mancini A., The leader peptide of a human rec. MnSOD as molecular carrier which delivers high amounts of cisplatin into tumor cells inducing a fast apoptosis in vitro. International Journal of Cancer 2011 128 2 453 459 2-s2.0-78649571038 10.1002/ijc.25334
120. Borrelli A., Schiattarella A., Musella A., Mancini R., Capasso C., De Luca V., Carginale V., Sanseverino M., Tornesello A. L., Gori E., Pica A., Di Santi A., Basile F., Iacobellis F., Colacurci N., Cobellis L., Mancini A., A molecular carrier to transport and deliver cisplatin into endometrial cancer cells. Chemical Biology & Drug Design 2012 80 1 9 16 2-s2.0-84860215396 10.1111/j.1747-0285.2012.01337.x
121. Guillaume M., Rodriguez-Vilarrupla A., Gracia-Sancho J., Rosado E., Mancini A., Bosch J., Garcia-Pagán J. C., Recombinant human manganese superoxide dismutase reduces liver fibrosis and portal pressure in CCI4 -cirrhotic rats. Journal of Hepatology 2013 58 2 240 246 10.1016/j.jhep.2012.09. 010
122. Damiano S., Trepiccione F., Ciarcia R., Scanni R., Spagnuolo M., Manco L., Borrelli A., Capasso C., Mancini R., Schiattarella A., Iervolino A., Zacchia E., Bata-Csere A., Florio S., Anastasio P., Pollastro R., Mancini A., Capasso G., A new recombinant MnSOD prevents the Cyclosporine A-induced renal impairment. Nephrology Dialysis Transplantation 2013 28 8 2066 2072 10.1093/ndt/gft020
123. Pisani A., Sabbatini M., Riccio E., Rossano R., Andreucci M., Capasso C., De Luca V., Carginale V., Bizzarri M., Borrelli A., Schiattarella A., Santangelo M., Mancini A., Effect of a recombinant manganese superoxide dismutase on prevention of contrast-induced acute kidney injury. Clinical and Experimental Nephrology 2013 10.1007/s10157-013-0828-2
124. Garcia-Espana A., Biria S., Malumbres M., Levin B., Meruelo D., Pellicer A., Targeted gene transfer system using a streptavidin-transforming growth factor- chimeric protein. DNA and Cell Biology 1999 18 10 743 749 2-s2.0-0032747302 10.1089/104454999314881 (Pubitemid 29504188)
125. Johnson M., Chemotherapy treatment decision making by professionals and older patients with cancer: a narrative review of the literature. European Journal of Cancer Care 2012 21 1 3 9 2-s2.0-84055184903 10.1111/j.1365-2354. 2011.01294.x
126. Garrett M. D., Collins I., Anticancer therapy with checkpoint inhibitors: what, where and when? Trends in Pharmacological Sciences 2011 32 5 308 316 2-s2.0-79955720082 10.1016/j.tips.2011.02.014
127. Yu C.-L., Tsai M.-H., Embryonic apoptosis-inducing proteins exhibited anticancer activity in vitro and in vivo. Anticancer Research 2001 21 3B 1839 1856 2-s2.0-0034897317 (Pubitemid 32728921)
128. Firuzi O., Miri R., Tavakkoli M., Saso L., Antioxidant therapy: current status and future prospects. Current Medicinal Chemistry 2011 18 25 3871 3888 2-s2.0-80052244346
129. Matés J. M., Segura J. A., Alonso F. J., Márquez J. M., Natural antioxidants: therapeutic prospects for cancer and neurological diseases. Mini-Reviews in Medicinal Chemistry 2009 9 10 1202 1214 10.2174/138955709789055180
130. Matés J. M., Segura J. A., Alonso F. J., Márquez J.,
131. Robbins D., Zhao Y., The role of manganese superoxide dismutase in skin cancer. Enzyme Research 2011 409295
132. de Souza Prestes A., Stefanello S. T., Salman S. M., Pazini A. M., Schwab R. S., Braga A. L., De Vargas Barbosa N. B., Rocha J. B. T., Antioxidant activity of β -selenoamines and their capacity to mimic different enzymes. Molecular and Cellular Biochemistry 2012 365 1-2 85 92 2-s2.0-84860256003 10.1007/s11010-012-1246-6
133. Safavi M., Foroumadi A., Nakhjiri M., Abdollahi M., Shafiee A., Ilkhani H., Ganjali M. R., Hosseinimehr S. J., Emami S., Complexes of 2-hydroxyacetophenone semicarbazones: a novel series of superoxide dismutase mimetics. Bioorganic & Medicinal Chemistry Letters 2010 20 10 3070 3073 2-s2.0-77952101405 10.1016/j.bmcl.2010.03.099
134. Thomas R., Sharifi N., SOD mimetics: a novel class of androgen receptor inhibitors that suppresses castration-resistant growth of prostate cancer. Molecular Cancer Therapeutics 2012 11 1 87 97 2-s2.0-84855709289 10.1158/1535-7163.MCT-11-0540
135. Fleenor B. S., Seals D. R., Zigler M. L., Sindler A. L., Superoxide-lowering therapy with TEMPOL reverses arterial dysfunction with aging in mice. Aging Cell 2012 11 2 269 276 2-s2.0-84858333077 10.1111/j.1474-9726. 2011.00783.x
136. Pan H., Marsh J. N., Christenson E. T., Soman N. R., Ivashyna O., Lanza G. M., Schlesinger P. H., Wickline S. A., Postformulation peptide drug loading of nanostructures. Methods in Enzymology 2012 508 17 39 2-s2.0-84859031194 10.1016/B978-0-12-391860-4.00002-1
137. Baudin B., New aspects on angiotensin-converting enzyme: from gene to disease. Clinical Chemistry and Laboratory Medicine 2002 40 3 256 265 2-s2.0-0036239324 10.1515/CCLM.2002.042 (Pubitemid 34428855)
138. Egusquiaguirre S. P., Igartua M., Hernández R. M., Pedraz J. L., Nanoparticle delivery systems for cancer therapy: advances in clinical and preclinical research. Clinical and Translational Oncology 2012 14 2 83 93 10.1007/s12094-012-0766-6
139. Paulo C. S. O., Pires das Neves R., Ferreira L. S., Nanoparticles for intracellular-targeted drug delivery. Nanotechnology 2011 22 49 2-s2.0-81855212480 10.1088/0957-4484/22/49/494002 494002
140. Hogg R. T., Thorpe P., Gerard R. D., Retargeting adenoviral vectors to improve gene transfer into tumors. Cancer Gene Therapy 2011 18 4 275 287 2-s2.0-79952901838 10.1038/cgt.2010.78
141. Kaneda Y., Update on non-viral delivery methods for cancer therapy: possibilities of a drug delivery system with anticancer activities beyond delivery as a new therapeutic tool. Expert Opinion on Drug Delivery 2010 7 9 1079 1093 2-s2.0-77955861749 10.1517/17425247.2010.510511
142. Namiki Y., Fuchigami T., Tada N., Kawamura R., Matsunuma S., Kitamoto Y., Nakagawa M., Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring. Accounts of Chemical Research 2011 44 10 1080 1093 2-s2.0-80054731100 10.1021/ar200011r
143. Zhai X., Huang W., Liu J., Pang Y., Zhu X., Zhou Y., Yan D., Micelles from amphiphilic block copolyphosphates for drug delivery. Macromolecular Bioscience 2011 11 11 1603 1610 2-s2.0-80355124473 10.1002/mabi.201100163
144. Pasquetto M. V., Vecchia L., Covini D., Digilio R., Scotti C., Targeted drug delivery using immunoconjugates: principles and applications. Journal of Immunotherapy 2011 34 9 611 628 2-s2.0-80055002179 10.1097/CJI.0b013e318234ecf5
145. Dinarvand R., Sepehri N., Manoochehri S., Rouhani H., Atyabi F., Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents. International Journal of Nanomedicine 2011 6 877 895 2-s2.0-80155194438 10.2147/IJN.S18905
146. Liu K., Wang X., Fan W., Zhu Q., Yang J., Gao J., Degradable polyethylenimine derivate coupled to a bifunctional peptide R13 as a new gene-delivery vector. International Journal of Nanomedicine 2012 7 1149 1162
147. Y. Yang, Y.-M. Zhang, Y. Chen, D. Zhao, J.-T. Chen, and Y. Liu, Construction of a graphene oxide based noncovalent multiple nanosupramolecular assembly as a scaffold for drug delivery, Chemistry, vol. 18, no. 14, pp. 4208-4215, 2012.